Related Experiment Video
Updated: Jun 9, 2026
07:37
Mouse Models for Graft Arteriosclerosis
Published on: May 14, 2013
Blocking interferon {beta} stimulates vascular smooth muscle cell proliferation and arteriogenesis
Stephan H Schirmer1, Pieter T Bot, Joost O Fledderus
1Department of Cardiology, Saarland University Hospital, 66421 Homburg/Saar, Germany. stephan.schirmer@uks.eu
The Journal of Biological Chemistry
|August 26, 2010
Summary
Interferon-beta (IFNβ) inhibits the growth of new blood vessels by arresting cell cycles and promoting cell death. Blocking IFNβ signaling enhances blood vessel formation and improves blood flow recovery.
Area of Science:
- Cardiovascular Biology
- Immunology
- Vascular Biology
Background:
- Increased interferon-beta (IFNβ) signaling is linked to poor coronary collateralization.
- IFNβ inhibits collateral artery growth, but the underlying mechanisms are unclear.
Purpose of the Study:
- To elucidate the mechanisms by which IFNβ inhibits arteriogenesis.
- To investigate the therapeutic potential of inhibiting IFNβ signaling for promoting collateral artery growth.
Main Methods:
- Whole genome expression analysis of monocytes from patients with chronic total coronary artery occlusion.
- In vitro studies using vascular smooth muscle cells (VSMC) and THP1 monocytes treated with IFNβ.
- In vivo studies using IFNAR1 knockout mice and femoral artery ligation model.
Main Results:
- IFNβ treatment induced cell-cycle arrest in VSMCs via p21 upregulation and increased apoptosis in monocytes.
- Inhibition of IFNβ receptor-1 (IFNAR1) enhanced VSMC proliferation and reduced p21 expression.
- IFNAR1 deficiency led to reduced monocyte apoptosis and improved hindlimb perfusion recovery after ligation.
Conclusions:
- IFNβ inhibits collateral artery growth by inducing VSMC cell-cycle arrest and monocyte apoptosis.
- Inhibiting IFNβ signaling promotes VSMC proliferation and enhances collateral artery formation, suggesting a therapeutic target.
More Related Videos
06:14Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
Published on: June 11, 2017
08:28Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:17Autoregulation of Blood Flow
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
01:16Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...